Document Detail

Genetic variants in IL1A and IL1B contribute to the susceptibility to 2009 pandemic H1N1 influenza A virus.
Jump to Full Text
MedLine Citation:
PMID:  23927441     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: Host genetic variations may contribute to disease susceptibility of influenza. IL-1A and IL-1B are important inflammatory cytokines that mediate the inflammation and initiate the immune response against virus infection. In this study, we investigated the relationship between single-nucleotide polymorphisms (SNPs) of Interleukin-1A (IL-1A) and Interleukin-1B (IL-1B) and the susceptibility to 2009 pandemic A/H1N1 influenza (A(H1N1)pdm09). 167 patients whom were confirmed with A(H1N1)pdm09 and 192 healthy controls were included in this study. Four SNPs (rs1304037, rs16347, rs17561, rs2071373) in IL1A gene and three SNPs (rs1143623, rs3917345, rs1143627) in IL1B gene were genotyped by using matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry platform, and the associations of the genetic variants of IL-1 with susceptibility to A(H1N1)pdm09 were then assessed.
RESULTS: The polymorphisms of rs17561 in IL1A gene and rs1143627 in IL1B gene were found to be associated with susceptibility to A(H1N1)pdm09 with P values of 0.016 (OR 2.031, 95%CI 1.238-3.331) and <0.001 (OR 1.922, 95%CI 1.426-2.590), respectively. However, no significant difference in allelic frequency was observed for other SNPs between cases and controls.
CONCLUSIONS: This study provides a new insight into pathogenesis of A(H1N1)pdm09, suggesting that genetic variants of IL-1A and IL-1B may exert a substantial impact on the susceptibility of A(H1N1)pdm09 virus infection.
Authors:
Yingxia Liu; Shaoyuan Li; Guoliang Zhang; Guang Nie; Zhizhong Meng; Dongting Mao; Chang Chen; Xinchun Chen; Boping Zhou; Gucheng Zeng
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-8-8
Journal Detail:
Title:  BMC immunology     Volume:  14     ISSN:  1471-2172     ISO Abbreviation:  BMC Immunol.     Publication Date:  2013 Aug 
Date Detail:
Created Date:  2013-8-9     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100966980     Medline TA:  BMC Immunol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  37     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): BMC Immunol
Journal ID (iso-abbrev): BMC Immunol
ISSN: 1471-2172
Publisher: BioMed Central
Article Information
Download PDF
Copyright ©2013 Liu et al.; licensee BioMed Central Ltd.
open-access:
Received Day: 14 Month: 5 Year: 2013
Accepted Day: 31 Month: 7 Year: 2013
collection publication date: Year: 2013
Electronic publication date: Day: 8 Month: 8 Year: 2013
Volume: 14First Page: 37 Last Page: 37
PubMed Id: 23927441
ID: 3750637
Publisher Id: 1471-2172-14-37
DOI: 10.1186/1471-2172-14-37

Genetic variants in IL1A and IL1B contribute to the susceptibility to 2009 pandemic H1N1 influenza A virus
Yingxia Liu1 Email: yingxialiu@hotmail.com
Shaoyuan Li2 Email: lwg1804@126.com
Guoliang Zhang1 Email: szdsyy@aliyun.com
Guang Nie1 Email: fqng1008@163.com
Zhizhong Meng3 Email: zzmeng@scut.edu.cn
Dongting Mao2 Email: michelle8_24@yahoo.cn
Chang Chen2 Email: cencangcc@qq.com
Xinchun Chen1 Email: chenxinchun@gmail.com
Boping Zhou1 Email: zhoubp@hotmail.com
Gucheng Zeng2 Email: zenggch@mail.sysu.edu.cn
1Guangdong Key Laboratory for Emerging Infectious Diseases, Shenzhen Third People’s Hospital, Guangdong Medical College, Shenzhen, China
2Department of Microbiology, Zhongshan School of Medicine, Key Laboratory for Tropical Diseases Control of the Ministry of Education, Sun Yat-sen University, Guangzhou, China
3School of Bioscience and Bioengineering, South China University of Technology, Guangzhou, China

Background

The global pandemic caused by the novel A(H1N1)pdm09 was first declared in Mexico and the United States in April 2009, inducing severe morbidity and mortality in a subset of the population [1]. This novel strain of influenza A virus is made up of a unique combination of gene segments from Eurasian swine, human and avian influenza viruses [2]. Thus, seasonal influenza vaccines do not confer effective cross-protection against A(H1N1)pdm09 virus infection. While the virulence and evolution of influenza virus have been intensively studied, the impact of host genetic background on the susceptibility to pandemic influenza virus infection remains largely unknown.

It has been suggested that the host genetic factors may affect the susceptibility and progression of microbial infections [3]. For example, Chinese population-attributable risk for severe influenza infection was ten-fold greater than Northern European population-attributable risk because of the high frequency of rs12252-C in Han Chinese [4]. Meanwhile, the SNPs in TLR3 [5], CD55 [6], C1q and FCGR2A [7], TNF [8,9], LTA, IL8 and IL1B [9] were suggested to be connected with the severity of A(H1N1)pdm09 virus infection.

During influenza virus infection, IL-1B has been demonstrated to mediate acute pulmonary inflammatory pathology [10]. Pro-IL-1B was cleaved by caspase-1 which was activated through the formation of the NLRP3 inflammasome [11]. Recent studies have shown that IL-1A secretion was also regulated by the NLRP3 inflammasome [12,13]. In addition, IL-1A and IL-1B induced the expression of a variety of inflammatory mediators, which may initiate the cascade of inflammatory responses and induced the activation of T cells [14,15]. To date, few studies have explored the association between IL-1 polymorphisms and A/H1N1 susceptibility [9]. Therefore, investigation of whether the genetic variants in IL-1 impact the susceptibility to A(H1N1)pdm09 is of great importance.

In this study, we examined 7 SNPs in IL1 gene and evaluated their association with A(H1N1)pdm09 susceptibility. The results indicated that rs17561 polymorphism in IL1A gene and rs1143627 polymorphism in IL1B gene, two novel SNPs of IL-1 gene, contributed to the susceptibility to A(H1N1)pdm09.


Methods
Study subjects and samples

167 patients with A(H1N1)pdm09 were recruited in Shenzhen Third People’s Hospital, China during 2009 influenza pandemic period. 167 patients (91 males and 76 females) were included in this study, and the average age of patients is 22.37 (SD = 11.95). The diagnosis of A(H1N1)pdm09 was followed the guideline released by the Ministry of Health of the People’s Republic of China. 192 Healthy donors (HD) were from Shenzhen, China during the same period, and no occurrence of A(H1N1)pdm09 was found in the HD during 1 year’s follow-up. 192 health individuals (101 males and 91 females) were recruited as controls, and the average age of healthy individuals is 24.53 (SD = 10.29). All subjects were Chinese Han people whom have received flu vaccine previously. Venous blood was drawn from all subjects after an overnight fasting. Blood corpuscles were stored at −80°C for DNA purification. The study was approved by the Institutional Review Board of Shenzhen Third People’s Hospital, and informed consent was obtained from each participant. There is no significant difference for the average age and gender distribution between cases and controls (P >0.05).

DNA extraction and SNP selection

Genomic DNA was obtained from peripheral blood samples, using the QIAamp DNA Blood Mini kit (Qiagen, Hilden, Germany) according to the manufacturer’s instruction. Isolated DNA was stored at −80°C before usage. SNPs were selected according to methods described previously [16], with focusing on their potential regulatory roles, such as transcription binding sites in the promoter region, microRNA target sites in the 3′ untranslated region (UTR), protein phosphorylation sites in the extrons and other putative regulation sites.

To search for the SNPs with alleles that alter the putative transcription factor binding sites, we scanned the promoter region of the gene in TRANSFAC database [17]. For the annotated SNPs in dbSNP129 that are within 2000 bp upstream to 500 bp downstream of the IL-1 gene, we extracted their flanking sequence (1-25 bp) from the dbSNP website (http://www.ncbi.nlm.nih.gov/projects/SNP/). We then used a PWM_SCAN Algorithm [18] to scan each sequence in the set to test whether it had a putative binding site (PBS), using the method described previously [19]. To search for the SNPs with alleles that alter the putative microRNA target sites, we first searched the PITA database for the microRNAs that could target the 3′ UTR region of the IL-1 gene. For the SNP that is in the target site, we obtained its flanking sequence (1-50 bp) from the UCSC genome browser according to its genomic location. We then tested whether the change of alleles also changed the microRNA target interaction by RNA hybridization. In addition, we used tagging procedure to select SNPs that cover the IL-1 gene [20], and chose the CHB + JPT HapMap panel, r2 = 0.8 and default settings for all other parameters. We also selected several other SNPs in the IL-1 gene region that were reported to be associated with disease severity [21-23]. The allelic variant substitution bases and the allele specific primer sequences were shown in Table 1.

Genotyping

SNPs’ genotyping was based on analysis of primer extension products generated from previously amplified genomic DNA using a chip-based MALDI-TOF mass spectrometry platform (Sequenom, San Diego, CA). The amplification PCR primer pairs and the extend primers were designed by MassARRAY assay designer software v3.1, in combination with manual adjustment (Table 1). PCR amplification was performed in the HotStar buffer system (Qiagen, Hilden, Germany). Extend products were dispensed onto a 384-spot plate, and Thermo cycling (Applied Biosystems, USA) was initiated at 94°C for 5 min; followed by 40 cycles of 94°C for 30 s, 55°C for 30 s, 72°C for 30 s; and a final extension of 72°C for 3 min to amplify identical length products. Following genomic amplification of the target regions, excess deoxyribonucleotide triphosphates were dephosphorylated with 2 μL shrimp alkaline phosphatase by incubation at 37°C for 60 min, and stopped by inactivation at 85°C for 10 min.

The selected SNPs were analyzed in one primer-extension reaction, the PCR was then performed at 94°C for 15 min, 40 cycles of 94°C for 5 s, (52°C for 5 s, and 80°C for 5 s, 5 cycles), followed by a final extension done at 72°C for 3 min. After desalting extension products for MALDI-TOF mass spectrometry analysis by the addition of 16 μL water and 6 mg of clean resin to each sample. Data analysis was performed by using MassARRAY typer software 4.0.

Statistical analysis

The frequencies of allele and genotype were determined by direct counting. All SNPs investigated in this study were tested for Hardy-Weinberg equilibrium. The Pearson χ2 test was used to compare allele and genotype distribution in cases and controls. Odds ratios (ORs) and their 95% confidence intervals (CI) were calculated with Miettinen’s method. Each SNP was calculated under four alternative models (dominant, recessive, multiplicative and additive), as previously described [4,24-26]. Bonferroni correction was used to compare the allelic frequency between participants with different genotypes. All the statistical procedures were performed with SPSS13.0 software. P <0.05 was considered to be significant.


Results
Selection and genotyping of IL1A/IL1B SNPs

To choose relevant SNPs for IL1A and IL1B gene, we considered about 100 known and rare variants, which are publicly available in database (dbSNP: http://www.ncbi.nlm.nih.gov/SNP/; CYPallele nomenclature: http://www.cypalleles.ki.se). After bioinformatic analysis and prediction for SNPs that may influence gene expression or protein structure and function, a total of 7 SNPs, including 4 in the IL1A gene (rs17561 G > T, rs1304037 A > G, rs2071373 C > T, rs16347 DEL > TGAA), and 3 in the IL1B gene (rs1143623 G > C, rs3917345 DEL > TGGT, rs1143627 T > C), were selected finally. The locations of these SNPs in IL-1 were shown in Figure 1. Rs2071373 is in the intron 3 and 209 bp after the extron 3 (the length from the coding sequence start site to the extron 3 is 96 bp) of IL1A gene. Rs17561 is in the extron 5 of IL1A gene and 340 bp after coding sequence (CDS) start site. Rs1304037 is in the 3′UTR of IL1A gene and 408 bp after CDS terminal site. Rs16347 is in the 3′UTR of IL1A gene, 922 bp after CDS terminal site and a 4 bp fraction is missing. 3 SNPs of IL1B gene are all in the promoter region. Rs1143623 is 1473 bp before the transcription start site of IL1B gene. Rs3917345 is 798 bp before the transcription start site of IL1B gene and a 4 bp fraction is missing. Rs1143627 is 31 bp before the transcription start site of IL1B gene. Genotypes of these 7 SNPs were determined using the MALDI-TOF mass spectrometry platform in a cohort of 167 cases and 192 controls. The intensities of mass signal of rs17561 and rs1143627 SNPs from three DNA samples analyzed by MALDI-TOF mass spectrum were shown in Figure 2.

Association of IL1A gene SNPs with A/H1N1 susceptibility

The genotypic frequencies of the two groups in these 4 SNPs were shown in Table 2. The distribution of genotype in patients with pH1N1/09 and healthy controls were coincident with Hardy-Weinberg equilibrium (P > 0.05). The T allele of rs17561 showed a two-fold increase in risk for influenza compared with the G allele (multiplicative model, P = 0.003, odds ratio, OR = 2.08, 95% confidence interval, CI 1.27-3.41). Under the dominant model, heterozygotes and homozygotes for the T allele had a two-fold increase of risk for influenza compared with homozygotes for the G allele (dominant model, P = 0.001, OR = 2.43, 95% CI 1.42-4.15). However, no significant differences in allelic frequencies for other SNPs were found between cases and controls. Thus, these data suggested that the rs17561 SNP, located on the extron of IL1A leading to Ser114Ala mutation, was associated with A(H1N1)pdm09 susceptibility.

Association of IL1B gene SNPs with A/H1N1 susceptibility

3 SNPs in IL1B were successfully genotyped and considered for genetic association tests (Table 3), and all these SNPs were consist with Hardy-Weinberg equilibrium (P >0.05). The rs1143627 SNP located on 31 base pairs upstream from the transcription start site of IL1B gene was evaluated for the association with increased risk of influenza susceptibility. Under the multiplicative model, the T allele showed an increase in risk for influenza compared with the C allele (multiplicative model, P = 0.002, OR = 1.62, 95% CI 1.20-2.18). Under the additive model, genotype TT had a two-fold higher risk for influenza compared with genotype CC (additive model, P = 0.005, OR = 2.38, 95% CI 1. 92–4.40). Under the dominant model, heterozygotes and homozygotes for the T allele had a two-fold higher risk for influenza compared with homozygotes for the C allele (dominant model, P = 0.002, OR = 1.99, 95% CI 1.28-3.09). Other 2 SNPs in IL1B showed no significant differences in allelic frequency among cases and controls. Thus, rs1143627 SNP in IL1B gene showed significant association with increased susceptibility to influenza.


Discussion

In this study, we analyzed the genetic factors impacting the susceptibility to A(H1N1)pdm09. We examined 7 SNPs in IL1A and IL1B genes and evaluated the association between SNPs of IL-1 and A(H1N1)pdm09 susceptibility. We found that rs17561 polymorphism in IL1A gene and rs1143627 polymorphism in IL1B gene contributed to the susceptibility to A(H1N1)pdm09.

In humans, IL-1 exists in two forms, IL-1A (encoded by IL1A gene) and IL-1B (encoded by IL1B gene), and both forms of IL-1 locate on chromosome 2 [27]. IL-1A and IL-1B are inflammatory cytokines that play important roles in recruitment of the immune and inflammatory cells and development of adaptive immune responses [28]. Accumulating evidence has suggested that IL-1A and IL-1B play important roles in innate immunity against viral infection. Infection of viruses such as, hepatitis A virus (HAV) [29], epstein-barr virus (EBV) [30], HIV [31] and human papilloma viruses (hrHPVs) [3], may activate the extracellular signal and induce production of IL-1. Several studies have documented an early rise in IL-1 in bronchoalveolar lavage (BAL) fluids or lung homogenates in temporal association with symptom formation and lung pathology after infection with A/PR/8/34 H1N1 or A(H1N1)pdm09 [32-34].

In fact, IL1A with rs17561 allele T has been suggested to be associated with immunopathogenesis of several diseases, including nasal polyposis [22], chronic rhinosinusitis [23]. Rs17561 polymorphism was related with high levels of C-reactive protein, which can regulate the severity inflammatory response [35]. Interestingly, our result also indicated that rs17561 allele T increased the risk of A(H1N1)pdm09 susceptibility. In contrast, rs1304037 and rs16347 locating on 3′UTR, and rs2071373 locating on intron box did not display any association with the susceptibility to A(H1N1)pdm09. The SNP rs17561 represents a nonsynonymous mutation (Ala114Ser) in IL-1A protein, suggesting that this mutation may lead to a potential functional variation in host susceptibility to A(H1N1)pdm09. However, the exact mechanism needs to be further studied.

During influenza virus infection, the immune response was triggered by the influenza virus ion channel M2 which was essential for virus entry and replication, leading to the assembly of inflammasome in macrophages and dendritic cells (DCs) [36]. Then, the activation of inflammasome resulted in the cleavage of pro-IL-1B by caspase-1 and produced the mature form of IL-1B [37]. IL-1B may act with IL-6 to induce IFN-γ production by T cells [14] and promote RORγt expression and Th-17 polarization of CD4 T cells [15]. The Th-17 effector cells produced IL-17 and facilitated the recruitment of neutrophils and inflammation [38].

Here, we found a significantly high frequency of IL-1B rs1143627 allele C in A/H1N1 patients, suggesting the hosts with allele C were more susceptible to this virus infection. Importantly,the frequency of the rs1143627 allele C is quite rich in Han Chinese (minor allele frequency = 0.476). Thus, elucidation of the underlying mechanism of the polymorphism of rs1143627 is of great importance for in-depth understanding of the susceptibility of influenza in Chinese population. Rs1143627 polymorphism involved the variation of IL-1B −31 allele C to T and is located on the TATA box of IL1B gene promoter region, which has been demonstrated to be a critical motif partially determining IL-1B transcriptional efficiency [39]. Furthermore, the rs1143627 and its franking sequences can be bound by transcription factors, including c/EBPβ, TBP and Spi-1 [40,41]. Electrophoretic mobility shift assay (EMSA) analysis suggested that c/EBPβ confers a much higher affinity to rs1143627-C probe than to T probe [40]. Several reports have shown that the allele T of rs1143627 enhanced IL-1B protein expression [40,42], and T-allele of rs1143627 was considered to be a pro-inflammatory allele [41]. People who carry allele T had a higher IL-1B expression that may promote the production of IFN-γ, which plays an important role in virus clearance [14]. IL-1B may also facilitate the differentiation and proliferation of pro-inflammatory cells such as Th-17 in humans [15,43]. In contrast, the expression of IL-1B may be much lower in people who carry allele C, leading to weaker immune response during viral infection.

Thus, it is possible that IL1B SNP rs1143627 C allele has a lower binding affinity to c/EBPβ and reduced levels of IL-1B expression, which may therefore weaken the inflammatory response of Th-17 and Th-1 cells in humans during influenza infection. A cohort of study with a larger population size is needed to further confirm the association of IL1A rs17561 allele T and IL1B rs1143627 allele C with an increased risk for the susceptibility to A(H1N1)pdm09. Functional studies will also be needed to further investigate the role and mechanism of genetic variants of IL-1 on the impact of susceptibility to A(H1N1)pdm09.


Conclusion

IL1A rs17561 allele T and IL1B rs1143627 allele C may confer an increased risk for the susceptibility to A(H1N1)pdm09. Thus, this study provides a new insight into the immunopathogenesis of influenza A virus infection in humans.


Abbreviations

SNPs: Single-nucleotide polymorphisms; IL: Interleukin; A(H1N1)pdm09: 2009 pandemic A/H1N1 influenza; MALDI-TOF: Matrix-assisted laser desorption/ionization time-of-flight; OR: Odds ratio; CI: Confidence interval.


Competing interests

The authors declare that they have no conflict of interests.


Authors’ contributions

YL, SL GZ and GN collected the samples, performed the experiments and analyzed the data. ZM, DM and CC analyzed the data. XC, BZ and GZ oversaw the research and wrote the manuscript. All authors read and approved the final manuscript.


Authors’ information

Y Liu, MD, PhD, Director, S Li, BS, G Zhang, MD, PhD, G Nie, PhD, Z Meng, PhD, D Mao, BS, C Chen, BS, X Chen, MD, PhD, B Zhou, MD, PhD, Dean, G. Zeng, PhD.


Acknowledgments

This work was supported by NSFC (No. 31170847 and No.30873264) and Shenzhen Science and Technology Foundation (No.201002107 and No.201202063) and Shenzhen Key Clinical Department of Emerging Infectious Diseases. We thank staffs, doctors and nurses of Shenzhen Third People’s Hospital for patient management, sample collection and analysis in this work.


References
Perez-Padilla R,De la Rosa-Zamboni D,Ponce De Leon S,Hernandez M,Quinones-Falconi F,Bautista E,Ramirez-Venegas A,Rojas-Serrano J,Ormsby CE,Corrales A,et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in MexicoN Engl J MedYear: 200914768068910.1056/NEJMoa090425219564631
Peiris JS,Hui KP,Yen HL,Host response to influenza virus: protection versus immunopathologyCurr Opin ImmunolYear: 201014447548110.1016/j.coi.2010.06.00320594815
Sabeti M,Kermani V,Sabeti S,Simon JH,Significance of human cytomegalovirus and Epstein-Barr virus in inducing cytokine expression in periapical lesionsJ EndodYear: 2012141475010.1016/j.joen.2011.09.02622152619
Zhang YH,Zhao Y,Li N,Peng YC,Giannoulatou E,Jin RH,Yan HP,Wu H,Liu JH,Liu N,et al. Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individualsNat CommunYear: 201314141823361009
Esposito S,Molteni CG,Giliani S,Mazza C,Scala A,Tagliaferri L,Pelucchi C,Fossali E,Plebani A,Principi N,Toll-like receptor 3 gene polymorphisms and severity of pandemic A/H1N1/2009 influenza in otherwise healthy childrenVirol JYear: 20121427010.1186/1743-422X-9-27023151015
Zhou J,To KK,Dong H,Cheng ZS,Lau CC,Poon VK,Fan YH,Song YQ,Tse H,Chan KH,et al. A functional variation in CD55 increases the severity of 2009 pandemic H1N1 influenza A virus infectionJ Infect DisYear: 201214449550310.1093/infdis/jis37822693232
Zuniga J,Buendia-Roldan I,Zhao Y,Jimenez L,Torres D,Romo J,Ramirez G,Cruz A,Vargas-Alarcon G,Sheu CC,et al. Genetic variants associated with severe pneumonia in A/H1N1 influenza infectionEur Respir J off J Eur Soc Clin Respir PhysiolYear: 2012143604610
Antonopoulou A,Baziaka F,Tsaganos T,Raftogiannis M,Koutoukas P,Spyridaki A,Mouktaroudi M,Kotsaki A,Savva A,Georgitsi M,et al. Role of tumor necrosis factor gene single nucleotide polymorphisms in the natural course of 2009 influenza A H1N1 virus infectionIJID Pub Int Soc Infect DisYear: 2012143e204e20810.1016/j.ijid.2011.11.012
Morales-Garcia G,Falfan-Valencia R,Garcia-Ramirez RA,Camarena A,Ramirez-Venegas A,Castillejos-Lopez M,Perez-Rodriguez M,Gonzalez-Bonilla C,Grajales-Muniz C,Borja-Aburto V,et al. Pandemic influenza A/H1N1 virus infection and TNF, LTA, IL1B, IL6, IL8, and CCL polymorphisms in Mexican population: a case–control studyBMC Infect DisYear: 20121429910.1186/1471-2334-12-29923148654
Schmitz N,Kurrer M,Bachmann MF,Kopf M,Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infectionJ VirolYear: 200514106441644810.1128/JVI.79.10.6441-6448.200515858027
Yazdi AS,Guarda G,D’Ombrain MC,Drexler SK,Inflammatory caspases in innate immunity and inflammationJ Innate ImmunYear: 201014322823710.1159/00028368820375549
Gross O,Yazdi AS,Thomas CJ,Masin M,Heinz LX,Guarda G,Quadroni M,Drexler SK,Tschopp J,Inflammasome activators induce interleukin-1alpha secretion via distinct pathways with differential requirement for the protease function of caspase-1ImmunityYear: 201214338840010.1016/j.immuni.2012.01.01822444631
Fettelschoss A,Kistowska M,LeibundGut-Landmann S,Beer HD,Johansen P,Senti G,Contassot E,Bachmann MF,French LE,Oxenius A,et al. Inflammasome activation and IL-1beta target IL-1alpha for secretion as opposed to surface expressionProc Natl Acad Sci U S AYear: 20111444180551806010.1073/pnas.110917610822006336
Luft T,Jefford M,Luetjens P,Hochrein H,Masterman KA,Maliszewski C,Shortman K,Cebon J,Maraskovsky E,IL-1 beta enhances CD40 ligand-mediated cytokine secretion by human dendritic cells (DC): a mechanism for T cell-independent DC activationJ ImmunolYear: 200214271372211777965
Acosta-Rodriguez EV,Napolitani G,Lanzavecchia A,Sallusto F,Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cellsNat ImmunolYear: 200714994294910.1038/ni149617676045
Zhang G,Chen X,Chan L,Zhang M,Zhu B,Wang L,Zhu X,Zhang J,Zhou B,Wang J,An SNP selection strategy identified IL-22 associating with susceptibility to tuberculosis in ChineseSci Rep Year: 2011142022355539
Matys V,Fricke E,Geffers R,Gossling E,Haubrock M,Hehl R,Hornischer K,Karas D,Kel AE,Kel-Margoulis OV,et al. TRANSFAC: transcriptional regulation, from patterns to profilesNucleic Acids ResYear: 200314137437810.1093/nar/gkg10812520026
Hannenhalli S,Putt ME,Gilmore JM,Wang J,Parmacek MS,Epstein JA,Morrisey EE,Margulies KB,Cappola TP,Transcriptional genomics associates FOX transcription factors with human heart failureCirculationYear: 200614121269127610.1161/CIRCULATIONAHA.106.63243016952980
Wang J,Zhang S,Schultz RM,Tseng H,Search for basonuclin target genesBiochem Biophys Res CommunYear: 20061441261127110.1016/j.bbrc.2006.07.19816919236
de Bakker PI,Yelensky R,Pe’er I,Gabriel SB,Daly MJ,Altshuler D,Efficiency and power in genetic association studiesNat GenetYear: 200514111217122310.1038/ng166916244653
Belfer I,Wu T,Hipp H,Walter J,Scully M,Nyquist PA,Bollettino A,Goldman D,Max MB,DeGraba TJ,Linkage of large-vessel carotid atherosclerotic stroke to inflammatory genes via a systematic screenInt J Stroke Off J Int Stroke SocYear: 201014314515110.1111/j.1747-4949.2010.00422.x
Erbek SS,Yurtcu E,Erbek S,Atac FB,Sahin FI,Cakmak O,Proinflammatory cytokine single nucleotide polymorphisms in nasal polyposisArch Otolaryngol Head Neck SurgYear: 200714770570910.1001/archotol.133.7.70517638785
Mfuna Endam L,Cormier C,Bosse Y,Filali-Mouhim A,Desrosiers M,Association of IL1A, IL1B, and TNF gene polymorphisms with chronic rhinosinusitis with and without nasal polyposis: a replication studyArch Otolaryngol Head Neck SurgYear: 201014218719210.1001/archoto.2009.21920157068
Lewis CM,Genetic association studies: design, analysis and interpretationBrief BioinformYear: 200214214615310.1093/bib/3.2.14612139434
Wang K,Sheffield VC,A constrained-likelihood approach to marker-trait association studiesAm J Hum GenetYear: 200514576878010.1086/49743416252237
Kim SW,Kim ES,Moon CM,Park JJ,Kim TI,Kim WH,Cheon JH,Genetic polymorphisms of IL-23R and IL-17A and novel insights into their associations with inflammatory bowel diseaseGutYear: 201114111527153610.1136/gut.2011.23847721672939
Haukim N,Bidwell JL,Smith AJ,Keen LJ,Gallagher G,Kimberly R,Huizinga T,McDermott MF,Oksenberg J,McNicholl J,et al. Cytokine gene polymorphism in human disease: on-line databases, supplement 2Genes ImmunYear: 200214631333010.1038/sj.gene.636388112209358
Dinarello CA,IL-1: discoveries, controversies and future directionsEur J ImmunolYear: 201014359960610.1002/eji.20104031920201008
Fierro NA,Escobedo-Melendez G,De Paz L,Realpe M,Roman S,Panduro A,Cytokine expression profiles associated with distinct clinical courses in hepatitis A virus-infected childrenPediatr Infect Dis JYear: 201214887087110.1097/INF.0b013e318258e80822531242
Kim SS,Cheong JY,Lee D,Lee SK,Kim MH,Kwack K,Yang SJ,Lee HY,Cho SW,Interleukin-1ss and interleukin-1 receptor accessory protein gene polymorphisms are associated with persistent hepatitis B virus infectionHepatogastroenterologyYear: 20121411319019722251538
Mamik MK,Banerjee S,Walseth TF,Hirte R,Tang L,Borgmann K,Ghorpade A,HIV-1 and IL-1beta regulate astrocytic CD38 through mitogen-activated protein kinases and nuclear factor-kappaB signaling mechanismsJ NeuroinflammationYear: 20111414510.1186/1742-2094-8-14522027397
Vacheron F,Rudent A,Perin S,Labarre C,Quero AM,Guenounou M,Production of interleukin 1 and tumour necrosis factor activities in bronchoalveolar washings following infection of mice by influenza virusJ Gen VirolYear: 199014Pt 24774792137872
Murphy EA,Davis JM,McClellan JL,Carmichael MD,Rooijen NV,Gangemi JD,Susceptibility to infection and inflammatory response following influenza virus (H1N1, A/PR/8/34) challenge: role of macrophagesJ Interferon Cytokine Res J Int Soc Interfer Cytokine ResYear: 201114650150810.1089/jir.2010.0143
Estella A,Cytokine levels in bronchoalveolar lavage and serum in 3 patients with 2009 Influenza A(H1N1)v severe pneumoniaJ Infect Dev CtriesYear: 201114754054321795823
Berger P,McConnell JP,Nunn M,Kornman KS,Sorrell J,Stephenson K,Duff GW,C-reactive protein levels are influenced by common IL-1 gene variationsCytokineYear: 200214417117410.1006/cyto.2001.097411991668
Ichinohe T,Pang IK,Iwasaki A,Influenza virus activates inflammasomes via its intracellular M2 ion channelNat ImmunolYear: 201014540441010.1038/ni.186120383149
Hornung V,Ablasser A,Charrel-Dennis M,Bauernfeind F,Horvath G,Caffrey DR,Latz E,Fitzgerald KA,AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASCNatureYear: 200914723751451810.1038/nature0772519158675
Weaver CT,Hatton RD,Mangan PR,Harrington LE,IL-17 family cytokines and the expanding diversity of effector T cell lineagesAnnu Rev ImmunolYear: 20071482185210.1146/annurev.immunol.25.022106.14155717201677
El-Omar EM,Carrington M,Chow WH,McColl KE,Bream JH,Young HA,Herrera J,Lissowska J,Yuan CC,Rothman N,et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancerNatureYear: 200014677639840210.1038/3500608110746728
Lind H,Haugen A,Zienolddiny S,Differential binding of proteins to the IL1B–31 T/C polymorphism in lung epithelial cellsCytokineYear: 2007141434810.1016/j.cyto.2007.05.00117587593
Zienolddiny S,Ryberg D,Maggini V,Skaug V,Canzian F,Haugen A,Polymorphisms of the interleukin-1 beta gene are associated with increased risk of non-small cell lung cancerInt J Cancer J Int du CancerYear: 200414335335610.1002/ijc.11695
Wobbe CR,Struhl K,Yeast and human TATA-binding proteins have nearly identical DNA sequence requirements for transcription in vitroMol Cell BiolYear: 1990148385938672196437
Yang L,Anderson DE,Baecher-Allan C,Hastings WD,Bettelli E,Oukka M,Kuchroo VK,Hafler DA,IL-21 and TGF-beta are required for differentiation of human T(H)17 cellsNatureYear: 200814720235035210.1038/nature0702118469800

Figures

[Figure ID: F1]
Figure 1 

Schematic representation of IL-1α and IL-1β genes. (A) is IL-1α and (B) is IL-1β gene. The boxes represent the exons. The black boxes represent coding sequences and grey boxes represent 3′ or 5′ untranslated regions. SNPs analyzed in this study are marked with an arrow. The first line following the direction of arrow marking the SNPs shows the SNP name (i.e. rs-number) from NCBI, and the second line shows the SNP position and the base substitution starting from the start codon.



[Figure ID: F2]
Figure 2 

MALDI–TOF mass spectrum–based analysis of rs17561 and rs1143627 SNPs. Typical MALDI-TOF MS spectra from three DNA samples are shown. Dashed lines mark the unextended primers and product/extended primers. Rs17561 SNP includes GG, GT, and TT genotypes, and rs1143627 SNP includes CC, TC, and TT genotypes.



Tables
[TableWrap ID: T1] Table 1 

Outline of primers for IL1A, IL1B SNP genotyping


Gene SNP ID Polymorphisms Forward primer
Reverse primer
Un-extension primer
(5′-3′) (5′-3′) (5′-3′)
IL1A
rs1304037
A > G
ACGTTGGATGTCGATTAAGAGTTCATCAGC
ACGTTGGATGAGCCACAGACCTAGGATTTC
AGTTCATCAGCAACTTAAAAG
rs16347
DEL > TGAA
ACGTTGGATGGTAGGACTTGATTGCAGGTG
ACGTTGGATGTTGAGCCAGTAATTGGTCCG
TGCAGGTGGAATTGAA
rs17561
G > T
ACGTTGGATGGGTTTTAGAAATCATCAAGCC
ACGTTGGATGGAATTCGTATTTGATGATCC
TCATCAAGCCTAGGTCA
rs2071373
C > T
ACGTTGGATGTGATGTGCATTGGCTTCTCC
ACGTTGGATGAACATCCTGATGAAGCCTGC
TCCCAGAACAGAGCAGAAC
IL1B rs1143623
G > C
ACGTTGGATGATGTGCCAGGTATCGTGCTC
ACGTTGGATGACCTATTTCCCTCGTGTCTC
GCTCGCTCTGCATTAT
rs3917345
DEL > TGGT
ACGTTGGATGTGCTGGTGTCTCGGTTAAAG
ACGTTGGATGTCTGAGACTCTATCTCTTGG
AGAGAAACTGATAACTCTTGGT
rs1143627 T > C ACGTTGGARGCCTCGAAGAGGTTTGGTATC ACGTTGGATGTCTAGCCTCCTACTTCTGC ATCCCTCGCTGTTTTTAT

[TableWrap ID: T2] Table 2 

Distribution of genotype and allele frequencies of IL1A SNP


Gene
Different genetics models
 
IL1A
 
Controls
Cases
Multiplicative
Additive
Dominant
Recessive
SNP ID Genotype No (%) No (%) P value OR P value OR (95% CI) P value OR (95% CI) P value OR (95% CI)
RS1304037
AA
161 (83.9)
130 (77.8)
0.262
1.32 (0.81-2.15)
 
 
0.147
1.48 (0.87-2.51)
0.386
0.38 (0.04-3.69)
AG
28 (14.6)
36 (21.6)
 
 
0.223
0.26 (0.03-2.63)
 
 
 
 
GG
3 (1.5)
1 (0.6)
 
 
0.432
0.41 (0.04-4.02)
 
 
 
 
rs16347
DEL/DEL
81 (42.2)
68 (40.7)
0.482
1.12 (0.82-1.51)
 
 
0.778
1.06 (0.70-1.62)
0.323
1.36 (0.74-2.48)
DEL/TGAA
88 (45.8)
73 (43.7)
 
 
0.343
1.36 (0.72-2.59)
 
 
 
 
TGAA/TGAA
23 (12.0)
26 (15.6)
 
 
0.367
1.35 (0.70-2.57)
 
 
 
 
rs17561
GG
166 (86.5)
121 (72.5)
0.003
2.08 (1.27-3.41)
 
 
0.001
2.43 (1.42-4.15)
0.646
0.54 (0.05-6.37)
GT
24 (12.5)
45 (26.9)
 
 
0.260
0.27 (0.02-3.10)
 
 
 
 
TT
2 (1.0)
1 (0.6)
 
 
0.758
0.69 (0.06-7.66)
 
 
 
 
rs2071373 CC
80 (41.7)
68 (40.7)
0.443
1.13 (0.83-1.53)
 
 
0.856
1.04 (0.68-1.59)
0.194
1.51 (0.81-2.84)
CT
92 (47.9)
74 (44.3)
 
 
0.191
1.55 (0.80-3.02)
 
 
 
 
TT 20 (10.4) 25 (15.0)     0.259 1.47 (0.75-2.88)        

CI, confidence interval; OR, odds ratio. The P values <0.05 were highlighted in boldface.


[TableWrap ID: T3] Table 3 

Distribution of genotype and allele frequencies of IL1B SNP


Gene
4 statistical models
 
IL1B
 
Controls
Cases
Multiplicative
Additive
Dominant
Recessive
SNP ID Genotype No (%) No (%) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI)
rs1143623
GG
57 (29.7)
37 (22.2)
0.106
1.27 (0.95-1.71)
 
 
0.105
1.48 (0.92-2.40)
0.318
1.28 (0.79-2.07)
GC
92 (47.9)
85 (50.9)
 
 
0.633
1.13 (0.68-1.89)
 
 
 
 
CC
43 (22.4)
45 (26.9)
 
 
0.11
1.61 (0.90-2.90)
 
 
 
 
rs3917345
DEL/DEL
191 (99.5)
166 (99.4)
0.541
1.15 (0.07-18.47)
 
 
0.541
1.15 (0.07-18.55)


DEL/TGGT
1 (0.5)
1 (0.6)
 
 


 
 
 
 
TGGT/TGGT
0 (0.0)
0 (0.0)
 
 


 
 
 
 
rs1143627 TT
84 (43.8)
47 (28.1)
0.002
1.62 (1.20-2.18)
 
 
0.002
1.99 (1.28-3.09)
0.063
1.68 (0.97-2.91)
TC
81 (42.2)
84 (50.3)
 
 
0.399
1.29 (0.72-2.31)
 
 
 
 
CC 27(14.1) 36 (21.6)     0.005 2.38 (1.29-4.40)        

CI, confidence interval; OR, odds ratio. The P values <0.05 were emphasized in boldface.



Article Categories:
  • Research Article

Keywords: Interleukin-1, H1N1, Influenza, Single-nucleotide polymorphisms (SNPs).

Previous Document:  The toxicity, transport and uptake of nanoparticles in the in vitro BeWo b30 placental cell barrier ...
Next Document:  A Designed Nanocage Displaying Ligand-Specific Peptide Bunches for High Affinity and Biological Acti...